AstraZeneca, Daiichi Sankyo Partnered ADC Shows Promise In Hard-To-Treat Breast CancerBenzinga • 05/10/21
Expert Panel Calls On Norway To Ditch AstraZeneca And Johnson & Johnson Covid Vaccines Over Blood Clot RisksForbes • 05/10/21
EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 ShotsBenzinga • 05/07/21
Here's Why The U.K. Is Offering Under-40s Alternatives To The AstraZeneca Covid-19 VaccineForbes • 05/07/21
UK to offer under-40s alternative to AstraZeneca Covid-19 vaccine given rare blood clot concernsCNBC • 05/07/21
The UK is offering people under 40 an alternative to AstraZeneca's COVID-19 vaccine following concerns about blood clots in young peopleBusiness Insider • 05/07/21
Under-40s to be offered alternative COVID-19 vaccines to AstraZeneca in U.K.: reportsMarket Watch • 05/07/21
AstraZeneca posts positive final-stage trial results for lung cancer treatmentProactive Investors • 05/07/21
Covid vaccine makers' shares seesaw after Biden administration says it will back patent waiversCNBC • 05/06/21
New Study Finds ‘Small' Blood Clot Risk After One AstraZeneca Vaccine Dose, Rates Are Higher Than Expected For General PopulationForbes • 05/06/21
Single Shot Of AstraZeneca, Pfizer COVID-19 Vaccines Provide 87% Protection, South Korea Study Shows: ReutersBenzinga • 05/05/21
AstraZeneca And Pfizer Covid-19 Vaccines More Than 86% Effective After First Dose, South Korean Authorities SayForbes • 05/05/21
Alchemab to Collaborate With AstraZeneca to Use Alchemab's Drug Discovery Platform for Prostate Cancer StudyBusiness Wire • 05/05/21
AstraZeneca shares have decoupled from vaccine headlines, says BarclaysProactive Investors • 05/04/21
AstraZeneca PLC's (AZN) CEO Pascal Soriot on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/01/21